CONCLUSION:
Despite its infrequency, TTM can substantially have a negative impact on mental status, life quality and psychosocial function, leading towards patient behavioral aberrancies. Identifying any potential comorbidity is essential to implement a thorough treatment plan. By identifying and characterizing subgroups of individuals based on their unique clinical features and comorbidities, we can gain more insight into the underlying mechanisms of this condition and develop more refined biological, genetic, and therapeutic studies. In this study, we present a patient with a diagnosis of TTM and BN with ongoing adult onset of ADHD as well as a history of MDD. Pharmacological treatments were planned and prescribed according to existing comorbidities to approach the patient’s clinical condition effectively. Current evidence also supports the use of a multidisciplinary approach including dermatologists, psychiatrists, counselors, and even family members to effectively support and treat the expanding and diverse patient group presenting with TTM and its multifaceted nature.